Olverembatinib (GZD824)
目录号: A16264
Bcr-Abl 抑制剂
GZD824 是一种新型口服生物利用度高的抑制剂,针对包括 T315I 在内的广谱 Bcr-Abl 突变体。
Discription | GZD824 is a novel orally bioavailable inhibitor against a broad spectrum of Bcr-Abl mutants including T315I. | |||||
---|---|---|---|---|---|---|
Cell Research |
|
目录号 | A16264 |
---|---|
分子式 | C29H27F3N6O |
分子量 | 532.22 |
CAS号 | 1257628-77-5 |
SMILES | CC1=CC=C(C=C1C#CC2=CN=C3C(C=NN3)=C2)C(NC4=CC=C(C(C(F)(F)F)=C4)CN5CCN(CC5)C)=O |
其他名称 | GZD 824, GZD-824 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2